0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $100 | November 2023
    Product Insights

    Gibson South Mine

    The Gibson South Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Gibson South Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...

  • Product Insights

    $100 | November 2023
    Product Insights

    Gibson Bay

    Gibson Bay is an Onshore Wind project located in Eastern Cape, South Africa. The project is owned by Enel Green Power South Africa BV and was developed by Enel Green Power South Africa BV; Red Cap Energy (Pty) Ltd. The project came online in 2017. Empower your strategies with our Gibson Bay report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3...

  • Product Insights

    $100 | November 2023
    Product Insights

    Gibson Power Plant

    Gibson Power Plant is a thermal project located in Indiana, United States. The project is owned by Duke Energy Indiana LLC; Indiana Municipal Power Agency; Wabash Valley Power Association Inc. The project came online in 1975. Empower your strategies with our Gibson Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...

  • Product Insights

    $100 | November 2023
    Product Insights

    Gibson-STEU Solar PV Park

    Gibson-STEU Solar PV Park is a solar PV project located in New York, United States. The project is owned and being developed by Abundant Solar Power Inc. The project is expected to come online in 2025. Empower your strategies with our Gibson-STEU Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...

  • Product Insights

    $100 | November 2023
    Product Insights

    Gibson Solar PV Park I

    Gibson Solar PV Park I is a solar PV project located in Indiana, United States. The project is owned by Capital Dynamics AG and is developed by Arevon Energy Management; Tenaska Inc. The project is at the permitting stage. Empower your strategies with our Gibson Solar PV Park I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...

  • Company Insights

    $399 | January 2024
    Company Insights

    Innovation and Patenting activity of Gibson Energy Inc Q4 2023

    GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Gibson Energy Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...

  • Product Insights

    New
    $500 | March 2024
    Product Insights
    New

    Likelihood of Approval and Phase Transition Success Rate Model – VRDN-002 in Graves’ Ophthalmopathy

    Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VRDN-002 in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VRDN-002 in Graves' Ophthalmopathy Drug Details: VRDN-002 is under development for the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pheochromocytoma – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pheochromocytoma - Drugs In Development, 2023’, provides an overview of the Pheochromocytoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pheochromocytoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Adrenal Gland Cancer – Drugs In Development, 2023

    Global Markets Direct’s, ‘Adrenal Gland Cancer - Drugs In Development, 2023’, provides an overview of the Adrenal Gland Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Adrenal Gland Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Malignant Glioma – Drugs In Development, 2023

    Global Markets Direct’s, ‘Malignant Glioma - Drugs In Development, 2023’, provides an overview of the Malignant Glioma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Malignant Glioma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.